Prime Minister’s office took lead on closing generic drug patent: memo says government obligated to protect patents, concerned about risks to government and followed treaty
The Prime Minister's Office appears to have thrown its weight behind recent drug regulations in an effort to help pharmaceutical giant Merck Frosst beat back competition from the generic drug manufacturers, The Hill Times has learned.
SPONSORED CONTENT
Get Weekend Point of View Newsletter
A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
